Histone deacetylase inhibition, histone demethylase inhibition, and hypomethylating agents are an active area of development for many cancers. MCC harbors numerous epigenetic changes as detailed in the text. The sTAg activates the lysine-specific histone demethylase (LSD1) and is required for tumorigenesis. This evidence concerns the gene KDM1A and cancer.